LncRNAs usually modulated disease progression through functioning on coding or non‐coding genes to boost or hinder the regulatory network within cellular processes.38, 39 This investigation held that the regulatory role of ANRIL in CAD was played via regulation of miR‐181b (Figures 3, 4, 5, 6), which has been a focus among CAD studies. The gene discussed is CDKN2B-AS1; the disease is coronary artery disorder.